3.44
Cardlytics Inc stock is traded at $3.44, with a volume of 25,099.
It is down -3.91% in the last 24 hours and down -20.00% over the past month.
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
See More
Previous Close:
$3.58
Open:
$3.54
24h Volume:
25,099
Relative Volume:
0.52
Market Cap:
$20.26M
Revenue:
$205.69M
Net Income/Loss:
$-104.00M
P/E Ratio:
-0.1692
EPS:
-20.3294
Net Cash Flow:
$-3.60M
1W Performance:
-12.24%
1M Performance:
-20.00%
6M Performance:
-62.26%
1Y Performance:
-83.54%
Cardlytics Inc Stock (CDLX) Company Profile
Name
Cardlytics Inc
Sector
Industry
Phone
888-798-5802
Address
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA
Compare CDLX vs APP, OMC, WPP, MGNI, LFTO
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CDLX
Cardlytics Inc
|
3.44 | 20.26M | 205.69M | -104.00M | -3.60M | -20.33 |
|
APP
Applovin Corp
|
315.25 | 105.50B | 6.16B | 3.91B | 4.40B | 11.34 |
|
OMC
Omnicom Group Inc
|
75.49 | 20.71B | 19.82B | 159.00M | 2.99B | 0.3998 |
|
WPP
Wpp Plc Adr
|
25.12 | 5.42B | 17.86B | -233.30M | 720.44M | -1.3469 |
|
MGNI
Magnite Inc
|
24.06 | 3.45B | 722.55M | 158.66M | 32.62M | 1.0355 |
|
LFTO
Liftoff Mobile Inc
|
16.09 | 2.72B | 0 | 0 | 0 | 0.00 |
Cardlytics Inc Stock (CDLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Initiated | Evercore ISI | In-line |
| Aug-16-24 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-08-24 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-08-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-08-24 | Downgrade | Needham | Buy → Hold |
| Jun-20-24 | Resumed | BofA Securities | Neutral |
| Jun-18-24 | Initiated | Northland Capital | Outperform |
| Mar-15-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-29-23 | Initiated | Lake Street | Buy |
| Sep-08-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-14-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-05-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | Needham | Buy |
| Apr-15-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-14-21 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-05-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-04-20 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-15-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-02-19 | Initiated | Craig Hallum | Buy |
| Nov-14-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-09-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Jul-01-19 | Initiated | William Blair | Outperform |
| Jan-15-19 | Upgrade | BofA/Merrill | Neutral → Buy |
View All
Cardlytics Inc Stock (CDLX) Latest News
Cardlytics, Inc.(NasdaqGM: CDLX) dropped from S&P Global BMI Index - marketscreener.com
Cardlytics stock holds near recent lows as investors weigh weak revenue and guidance - AD HOC NEWS
Cardlytics Stock Price Forecast. Should You Buy CDLX? - StockInvest.us
Cardlytics stock jumps after reverse split and strong recent gains - AD HOC NEWS
Cardlytics (NASDAQ: CDLX) Resolves Amit Jain Indemnification Dispute with $6.4M Settlement - kalkinemedia.com
CDLX|Cardlytics Inc|Price:4.130|Chg%:-0.150 - TradingKey
Cardlytics (CDLX) amends earlier insider stock report - Stock Titan
Cardlytics (NASDAQ: CDLX) revises earlier insider trade filing - Stock Titan
Cardlytics (NASDAQ: CDLX) amends earlier insider trade report - stocktitan.net
Cardlytics (CDLX) Latest Quarter: EPS Beats Its Estimate in the Latest Session; Latest Reaction: The Stock Closes Near Unchanged for the Current SessionPost-Earnings Reaction - vinanet.vn
Cardlytics (CDLX) Results Check: The EPS Result Is Above Expectation for the Current Session; Shares Show Little Net Change in Latest TradingEarnings Analysis - siam.in
Cardlytics (CDLX) Results Breakdown: EPS Clears the Reported Estimate in the Latest Session; Market Response: Shares Move Higher 1.73% in the Current UpdateUpward Estimate Revision - vinanet.vn
Cardlytics (CDLX) Q2 2026 Earnings Call Transcript - AOL.com
Cardlytics CEO Amit Gupta disposes of 13,461 common shares for $53,974 - Bitget
Cardlytics (CDLX) CEO sells shares outside 10b5-1 plan - Stock Titan
Cardlytics (CDLX) insider plans sale including tax-cover shares - Stock Titan
Klarna stock plunges 20% on trimmed guidance as German retail sales slow - AOL.com
Cardlytics Inc (CDLX) (Q2 2026) Earnings Call Highlights: Advert - GuruFocus
Cardlytics (NASDAQ: CDLX) insider plans to sell up to 6,785 shares - Stock Titan
CDLX Q2 2026 Earnings: Loss Per Share Beats Estimates by 41.18%, Stock Slips 0.7%Profit Inflection Point - vinanet.vn
Creatd: Q2 Earnings Snapshot - AOL.com
Cardiff Oncology: Q2 Earnings Snapshot - AOL.com
Kardigan: Q2 Earnings Snapshot - AOL.com
Cardlytics Inc (CDLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BofA Adjusts Price Target on Cardlytics to $4 From $8 - marketscreener.com
Kingsway: Q2 Earnings Snapshot - AOL.com
Cardlytics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
CDLX Looks 77.1% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
CDLX Looks 77.0% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Earnings call transcript: Cardlytics Q2 2026 results show recovery signs By Investing.com - Investing.com Nigeria
Is Cardlytics Inc (CDLX) Facing a Value Trap After Q2 Report? EPS -$2.30 on Revenue of $36.9M; GF Score: 34/100 - GuruFocus
CDLX Looks 77.1% Undervalued on GF Value™ but Faces Value Trap R - GuruFocus
CDLX: Advertiser growth, improved churn, and U.K. expansion offset year-over-year revenue declines - TradingView
Earnings call transcript: Cardlytics Q2 2026 results show recovery signs - Investing.com
Cardlytics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cardlytics, Inc. Common Stock (CDLX) Q2 FY2026 earnings call transcript - Yahoo Finance
CARDLYTICS ($CDLX) Releases Q2 2026 Earnings - Quiver Quantitative
CDLX: Q2 2026 revenue fell 36% to $36.9M, with a $14.9M net loss and a strategic shift after the Bridg sale - TradingView
Cardlytics Q2 revenue slightly misses estimates as billings fall - TradingView
Cardlytics, Inc. 2026: Revenue $36.88M, EPS ($1.5) — 10-Q Summary - TradingView
Cardlytics (NASDAQ: CDLX) Q2 revenue falls as FI partner exits - Stock Titan
CDLX: Revenue and billings fell sharply in Q2 2026, but margins improved and Q3 declines are expected to moderate - TradingView
Cardlytics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cardlytics: Q2 Earnings Snapshot - marketscreener.com
BRIEF-Cardlytics Q2 Revenue USD 36.882 Million - TradingView
Cardlytics, Inc. Provides Unaudited Earnings Guidance for the Third Quarter of 2026 - marketscreener.com
CDLX Q2'26 Earnings: EPS estimate is (2.30) USD - TradingView
Cardlytics (CDLX) awards 50,000 RSUs to its chief legal & privacy officer - Stock Titan
Cardlytics Inc expected to post a loss of $1.35 a shareEarnings Preview - TradingView
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 01net
Cardlytics Appoints Former Iterable Executive Chris Cheng As Chief Legal Officer - Pulse 2.0
Cardlytics Inc Stock (CDLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):